|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Dobutamine#Use in Specific Populations]] |
| {{Dobutamine}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
|
| |
|
| ===Pregnancy===
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| '''Pregnancy Category B'''
| |
| | |
| '''Teratogenic Effects :'''
| |
| Reproduction studies performed in rats at doses up to the normal human dose (10 mcg/kg/min for 24 h, total daily dose of 14.4 mg/kg) and in rabbits at doses up to 2 times the normal human dose have revealed no evidence of harm to the fetus due to dobutamine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
| |
| | |
| ===Labor and Delivery===
| |
| | |
| The effect of dobutamine injection on labor and delivery is '''unknown'''.
| |
| | |
| ===Nursing Mothers===
| |
| | |
| It is '''not known''' whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when dobutamine hydrochloride is administered to a nursing woman. If a mother requires dobutamine treatment, breast-feeding should be discontinued for the duration of the treatment.
| |
| | |
| ===Pediatric Use===
| |
| | |
| The safety and effectiveness of dobutamine injection for use in pediatric patients have not been studied.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb842dc2-fb15-48f9-e4b1-ea4280db0199 | publisher = | date = | accessdate = }}</ref>
| |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]] | |